ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREOF, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER AND a-D-GALACTOSIDASE

摘要

The invention relates to a pharmaceutical formulation or composition in the form of a tablet, coated tablet, capsule or powder for reconstitution, for use in irritable bowel syndrome, comprising an intestinal motility modifier and enzyme a-D-galactosidase.